| Financial Year |
March 31 2023 |
| Monetary Funds |
3,450,810,617.89 |
| Held-for-trading Financial Assets |
5,070,502,055.33 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,252,180,529.19 |
| Advances to Suppliers |
84,004,846.35 |
| Other Receivables |
38,064,072.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,260,390.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,439,622,596.08 |
| Other Current Assets |
43,752,247.98 |
| Total Current Assets |
11,500,261,647.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,939,737,051.19 |
| Investment Properties |
-- |
| Fixed Assetes |
519,991,312.96 |
| Under-construction Projects |
5,055,184.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,856,779.05 |
| R&D expenses |
-- |
| Goodwill |
167,683,770.62 |
| Long-Term Deferred and Prepaid Expenses |
18,942,119.71 |
| Deferred Income Tax Assets |
912,922,733.16 |
| Other Non-Current Assets |
2,558,450,161.88 |
| Sub-Total of Non-Current Assets |
12,837,664,770.79 |
| Total Assets |
24,337,926,417.91 |
| Short-Term Loans |
9,453,684.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
144,324,229.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
266,071,783.14 |
| Taxes Payable |
477,079,413.25 |
| Interest Payable |
-- |
| Dividend Payable |
5,920,703.70 |
| Other payables |
1,081,931,336.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,127,223,407.08 |
| Other Current Liabilities |
54,825,608.05 |
| Sub-Total of Current Liabilities |
5,095,209,027.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
228,407,716.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,001,860,743.78 |
| Total Liabilities |
6,097,069,771.14 |
| Paid-In Capital(Or Share Stock) |
328,300,769.56 |
| Capital Surplus |
380,728,904.31 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
17,666,899,416.70 |
| Minority Stockholder's Interest |
362,068,602.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,878,788,043.94 |
| Owner's Equity（Stockholder's Equity） |
18,240,856,646.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,337,926,417.91 |
